Helio Genomics and Quest Diagnostics have partnered to expand access to a blood-based liver cancer test across the U.S. Starting in April, providers with a Quest account will be able to order ...
WASHINGTON -- An investigational multi-target blood test was three times more sensitive than standard ultrasound surveillance for detecting early hepatocellular carcinoma (HCC), according to a ...
The US FDA has approved Wako Diagnostics’s new LBA AFP-L3 test system. It is intended for the risk assessment of developing hepatocellular carcinoma (HCC), liver cancer in patients with chronic liver ...
Researchers have recently created a blood test that can detect liver disease years before symptoms ever develop, helping pave the way for the diagnosis of diseases such as cirrhosis and liver cancer ...
Adapting Yoga Therapy to Meet the Needs of Inpatients Undergoing Hematopoietic Stem Cell Transplantation: Insights From an International, Multisite, Qualitative Study Hepatocellular carcinoma (HCC) is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results